Medtronic PLC (MDT) Balance Sheet
A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally.
Total Assets Chart for Medtronic PLC
Medtronic PLC (MDT) total assets for FY2026 were USD 93.0B, a 1.5% change from FY2025. Medtronic PLC's total assets grew from USD 527.4M in 1986 to USD 93.0B in 2026 (17539.0% over 40 years). Total assets compound annual growth rate: 5-year CAGR of -0.0%, 10-year CAGR of -0.7%, 20-year CAGR of 8.1%.
Total Assets (US Dollars)
R&D as % of Revenue
Compare with
Key Stats
- Market Cap
- $117.99B
- Implied Share Price
- $92.18
- Enterprise Value
- $136.55B
- Revenue (TTM)
- $36.36B
- EBITDA
- $10.10B
- Profit Margin
- 13.20%
- Trailing P/E
- 24.71
- Forward P/E
- 15.43
- Price/Book (MRQ)
- 2.38
- Price/Sales (TTM)
- 3.24
- EV/EBITDA
- 13.92
- EV/Revenue
- 3.76
- Dividend Yield
- 0.00%
- Book Value
- $38.64
- Free Cash Flow (FY2026)
- $5.43B
- Free Cash Flow Yield
- 4.60%
Snapshot as of 3rd September 2026 — not point-in-time controlled, may lag the live market by a few days.